Skip to main content
Home
language-selector-globe Sandoz | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | es
Brazil | pt
Canada | en
Canada | fr
Mexico | es
United States | en
Australia | en
Japan | ja
Korea | ko
Mainland China | zh
Austria | de
Belgium | fr
Belgium | nl
Bulgaria | bg
Croatia | hr
Czech Republic | cs
Denmark | da
Finland | fi
France | fr
Germany | de
Hungary | hu
Italy | it
Netherlands | nl
Norway | no
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Slovakia | sk
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
United Kingdom | en
Global | en
Sandoz | en
Saudi Arabia | ar
Turkey | tr
language-selector-globe Sandoz
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | es
Australia | en
Austria | de
Belgium | fr
Belgium | nl
Brazil | pt
Bulgaria | bg
Canada | en
Canada | fr
Croatia | hr
Czech Republic | cs
Denmark | da
Finland | fi
France | fr
Germany | de
Hungary | hu
Italy | it
Japan | ja
Korea | ko
Mainland China | zh
Mexico | es
Netherlands | nl
Norway | no
Global | en
Sandoz | en
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Saudi Arabia | ar
Slovakia | sk
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
Turkey | tr
United Kingdom | en
United States | en
    • About Sandoz 
      • Our Purpose and Ambition 
      • What We Do 
      • Innovation, Quality and Supply 
      • Corporate Responsibility 
        • Ethics, Risk and Compliance 
        • Sandoz external funding 
        • Malaria Initiative 
        • Novartis Access 
        • World Child Cancer 
      • Our History 
      • Investor Information 
      A girl with a flower About Sandoz
    • Products & Services 
      • Disease Areas 
        • Anti-Infectives 
        • Respiratory 
        • Endocrinology 
        • Immunology 
        • Oncology 
      • Biopharmaceuticals 
        • Value of Biosimilars 
        • Sandoz Biosimilar Portfolio 
        • Sandoz Biosimilar Pipeline 
        • About Biologics 
        • Science of Biosimilars 
        • Information for Patients 
      • Prescription Medicines 
      • Over-The-Counter Medicines 
      • Partnerships and Collaborations 
        • Biotech Cooperations 
        • Business to Business (B2B) 
      00181_300dpi_RGB Products & Services
    • People & Culture 
      • Board of Directors 
      • Sandoz Leadership 
        • Richard Saynor 
        • Francisco Ballester 
        • Martin Bischof 
        • Colin Bond 
        • Pierre Bourdage 
        • Valerie Chew 
        • Claire D'Abreu-Hayling 
        • Glenn A. Gerecke, PhD 
        • Rebecca Guntern 
        • Keren Haruvi 
        • Tripti Jha 
        • Steffen Kurzawa 
        • Ingrid Sollerer 
      • Diversity & Inclusion 
      • Associate Stories 
    • Investors & Media 
      • Sandoz spin-off 
      • Media Releases 
      • Media Library 
      • Media Contacts 
      • Novartis Annual Reporting Suite 
    • Careers 
      • Diversity & Inclusion 
      • Associate Stories 
      • Job Search 
      • Our Teams 
        • Sandoz Technology 
        • Sandoz People & Organization 
      • Personal Growth & Learning at Sandoz 
      • Flexible-Hybrid Working at Sandoz 
      • People & Culture 
      • Diversity & Inclusion 
      • Rewards & Recognition 
      Sandoz Careers Careers
    • News 
      • News Archive 
      • Media Releases 
      • Publications 
      • Stay Up-To-Date 
      A photo of people in a meeting hall News
    • Contacts 
    working at sandoz Home
Header
A girl with a flower

About Sandoz

Previous Next
Sandoz is a global leader in generic pharmaceuticals and biosimilars. Our purpose is pioneering novel approaches to help people around the world access high-quality medicine.
sandoz corporate video

Our Purpose and Ambition

At Sandoz, we discover new ways to improve and extend people’s lives and pioneer novel approaches to help people around the world access high-quality medicine.

A hand with a pill tray

What We Do

At Sandoz our work is focused on improving access to medicines, access to medical information and access to medical capacity building.

global burden diseases study

Innovation, Quality and Supply

We have a long history of innovating to increase access to high-quality, affordable medicines to millions of patients around the world.

corporate responsibility_1

Corporate Responsibility

Sandoz is a global leader in generic pharmaceuticals and biosimilars and a division of the Novartis Group. Our purpose is to discover new ways to improve and extend people’s lives.

Medicines start their journey from the pharmaceutical manufacturing site

Our History

The Sandoz brand is a seal of quality, and healthcare professionals around the world trust it as a symbol of high-quality, affordable medications.

Sandoz Leadership
Biopharmaceuticals
Careers

Sandoz Global

Key resources
  • Patients & Caregivers
  • Job seekers
  • Investors
  • Media
Recent updates
  • Sandoz spin-off
Explore
  • Contacts
  • Locations
  • Biosimilar Portfolio and Pipeline
Sandoz Companies
  • 1A Pharma
  • Hexal
  • Lek
Footer Bottom
© 2023 Sandoz International GmbH
  • Terms of Use
  • Privacy
  • About Cookies
  • Legal Notice
  • Social Media Community Guidelines
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for a global audience